Oncoinvent ASA Statistics
Oncoinvent ASA (BRRGF) Stock Statistics & Valuation Metrics
Total Valuation
Oncoinvent ASA has a market cap or net worth of $40.82M. The enterprise value is $120.97M.
- Market Cap
- $40.82M
- Enterprise Value
- $120.97M
Share Statistics
Oncoinvent ASA has 6,128,412 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 6,128,412
- Owned by Insiders
- ―
- Owned by Institutions
- ―
Financial Efficiency
Oncoinvent ASA’s return on equity (ROE) is -1.14 and return on invested capital (ROIC) is -122.44%.
- Return on Equity (ROE)
- -1.14
- Return on Assets (ROA)
- -0.89
- Return on Invested Capital (ROIC)
- -122.44%
- Return on Capital Employed (ROCE)
- -1.22
- Revenue Per Employee
- 20.19K
- Profits Per Employee
- -3.32M
- Employee Count
- 42
- Asset Turnover
- 0.01
- Inventory Turnover
- 0.00
Valuation Ratios
The current PE Ratio of Oncoinvent ASA is -0.35. Oncoinvent ASA’s PEG ratio is -0.02.
- PE Ratio
- -0.35
- PS Ratio
- 56.69
- PB Ratio
- 0.39
- Price to FCF
- -0.31
- Price to Operating Cash Flow
- -0.31
- PEG Ratio
- -0.02
Income Statement
In the last 12 months, Oncoinvent ASA had revenue of 848.00K and earned -139.28M in profits. Earnings per share was -3.95.
- Revenue
- 848.00K
- Gross Profit
- 848.00K
- Operating Income
- -151.23M
- Pretax Income
- -139.28M
- Net Income
- -139.28M
- EBITDA
- -134.13M
- Earnings Per Share (EPS)
- -3.95
Cash Flow
In the last 12 months, operating cash flow was -153.20M and capital expenditures 0, giving a free cash flow of -153.20M billion.
- Operating Cash Flow
- -153.20M
- Free Cash Flow
- -153.20M
- Free Cash Flow per Share
- -3.92
Dividends & Yields
Oncoinvent ASA pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -318.65%
- Earnings Yield
- -289.70%
Stock Price Statistics
- Beta
- 0.00
- 52-Week Price Change
- 0.00%
- 50-Day Moving Average
- 0.03
- 200-Day Moving Average
- 0.03
- Relative Strength Index (RSI)
- ―
- Average Volume (3m)
- ―
Important Dates
Oncoinvent ASA upcoming earnings date is Nov 17, 2026, TBA (Not Confirmed).
- Last Earnings Date
- Aug 27, 2026
- Next Earnings Date
- Nov 17, 2026
- Ex-Dividend Date
- ―
Financial Position
Oncoinvent ASA as a current ratio of 4.79, with Debt / Equity ratio of 0.67%
- Current Ratio
- 4.79
- Quick Ratio
- 4.79
- Debt to Market Cap
- 0.00
- Net Debt to EBITDA
- 1.04
- Interest Coverage Ratio
- -32.18
Taxes
In the past 12 months, Oncoinvent ASA has paid 0 in taxes.
- Income Tax
- 0
- Effective Tax Rate
- 0.00
Enterprise Valuation
Oncoinvent ASA EV to EBITDA ratio is 0.67, with an EV/FCF ratio of 0.60.
- EV to Sales
- -107.62
- EV to EBITDA
- 0.67
- EV to Free Cash Flow
- 0.60
- EV to Operating Cash Flow
- 0.60
Balance Sheet
Oncoinvent ASA has $140.16M in cash and marketable securities with $818.00K in debt, giving a net cash position of $139.34M billion.
- Cash & Marketable Securities
- $140.16M
- Total Debt
- $818.00K
- Net Cash
- $139.34M
- Net Cash Per Share
- $22.74
- Tangible Book Value Per Share
- $3.14
Margins
Gross margin is -1952.12%, with operating margin of -17964.74%, and net profit margin of -16424.65%.
- Gross Margin
- -1952.12%
- Operating Margin
- -17964.74%
- Pretax Margin
- -16424.65%
- Net Profit Margin
- -16424.65%
- EBITDA Margin
- -15976.77%
- EBIT Margin
- -16030.54%
